Akari Therapeutics Plc (AKTX) stock
AKTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$5.70−0.81 (-12.44%)
Close on Nov 17, 2026Market cap $11.10MP/E –Yield –
Akari Therapeutics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Akari Therapeutics's total debt was $200.00K at Sep 30, 2024.
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2024 | Sep 30, 2024 | $200.00K | – |
| Q2 FY2024 | Jun 30, 2024 | $600.00K | – |
| Q1 FY2024 | Mar 31, 2024 | $900.00K | – |
See a number that looks wrong?